Brokerages Set Align Technology, Inc. (NASDAQ:ALGN) Price Target at $215.00

Shares of Align Technology, Inc. (NASDAQ:ALGN) have been assigned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $215.00.

A number of research firms have issued reports on ALGN. Mizuho set a $210.00 target price on shares of Align Technology in a research note on Thursday, July 31st. Wells Fargo & Company reduced their price objective on shares of Align Technology from $246.00 to $199.00 and set an “overweight” rating for the company in a research note on Thursday, July 31st. Piper Sandler lowered their target price on shares of Align Technology from $250.00 to $190.00 and set an “overweight” rating on the stock in a research report on Thursday, July 31st. Stifel Nicolaus cut their target price on Align Technology from $275.00 to $200.00 and set a “buy” rating on the stock in a report on Thursday, July 31st. Finally, Zacks Research upgraded Align Technology from a “strong sell” rating to a “hold” rating in a research note on Tuesday.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $128.70 on Friday. Align Technology has a one year low of $122.00 and a one year high of $246.19. The business’s 50-day moving average price is $141.67 and its two-hundred day moving average price is $165.94. The company has a market capitalization of $9.33 billion, a P/E ratio of 21.70, a price-to-earnings-growth ratio of 1.44 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.06 billion. During the same period last year, the business earned $2.41 earnings per share. The firm’s revenue for the quarter was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. On average, equities analysts anticipate that Align Technology will post 7.98 EPS for the current year.

Align Technology announced that its Board of Directors has initiated a share repurchase program on Tuesday, August 5th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to reacquire up to 2% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling

In other news, CEO Joseph M. Hogan purchased 7,576 shares of the company’s stock in a transaction dated Friday, August 1st. The shares were bought at an average price of $131.49 per share, with a total value of $996,168.24. Following the completion of the transaction, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This trade represents a 4.27% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.66% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Teacher Retirement System of Texas acquired a new position in Align Technology during the 1st quarter worth $1,647,000. Asset Management One Co. Ltd. increased its stake in shares of Align Technology by 14.5% in the first quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider’s stock worth $5,024,000 after purchasing an additional 4,009 shares during the period. Czech National Bank lifted its position in shares of Align Technology by 3.3% during the 2nd quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider’s stock worth $3,153,000 after purchasing an additional 537 shares during the last quarter. Acadian Asset Management LLC bought a new stake in Align Technology during the 1st quarter valued at approximately $20,194,000. Finally, Parallel Advisors LLC grew its holdings in Align Technology by 66.0% in the 2nd quarter. Parallel Advisors LLC now owns 1,044 shares of the medical equipment provider’s stock valued at $198,000 after buying an additional 415 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.